Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Death-Defying Approach Devised by Penn Scientists to Prevent Cell Apoptosis


When recovering from a heart attack or stroke, the body must restore blood flow in order to resupply cells with oxygen. Ironically, the process of reoxygenation - so necessary for full recovery - also generates reactive oxygen species (ROS), molecules that induce apoptosis, or cellular death. Now, researchers at the University of Pennsylvania School of Medicine and the University of Iowa have identified a biochemical strategy to block ROS - which effectively prevents cellular damage and death. Their study is published in February’s Proceedings of the Natural Academy of Sciences.

“We’ve known that oxidation can induce apoptosis,” said Toshinori Hoshi, PhD, Associate Professor in Penn’s Department of Physiology. “We also knew that the enzyme methionine sulfoxide reductase type A - or MSRA - is a catalyst in reversing the oxidation of the amino acid methionine, an important building block of proteins.”

After using gene-transfer technology to insert extra MRSA into cells, the researchers noticed that the enzyme-packed cells were now protected from the damaging effects of ROS. “Not only were cells protected by an overproduction of MRSA, but our tests showed that the adverse oxidation process was reversed,” explains Hoshi.

“Oxidative stress is thought to be associated with many medical conditions, such as diseases related to aging and the heart,” continues Hoshi. “Given our findings, it may be possible to prevent such stress, and thereby treat disease, by boosting the amount of MSRA in the body so its protein-repair properties are unleashed.”

This research is funded by the National Institutes of Health.

Jen Miller | University of Pennsylvania
Further information:

More articles from Health and Medicine:

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

Im Focus: ILA 2018: Laser alternative to hexavalent chromium coating

At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.

When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

Earlier flowering of modern winter wheat cultivars

20.03.2018 | Agricultural and Forestry Science

Smithsonian researchers name new ocean zone: The rariphotic

20.03.2018 | Life Sciences

Molecular doorstop could be key to new tuberculosis drugs

20.03.2018 | Life Sciences

Science & Research
Overview of more VideoLinks >>>